Strategic Tech & Business Innovation

Celebrating 40 years, Scenic Group announces three new luxury river ships, signaling its most significant growth phase in a decade for 2027 and 2028.

Ohio-based marketing firm Think Patented nearly doubled its B2B storefronts by consolidating legacy systems onto a single web-to-print automation platform.

Despite a $17.7M Q4 loss, the REIT is overhauling its balance sheet and betting its future on a strategic shift to the booming multifamily market.

Redbreast's 'Unhidden' initiative evolves at SXSW, with Andrew Scott now executive producing, offering emerging filmmakers an unprecedented career launchpad.

Gaming and Leisure Properties' new investor presentation reveals record profits and a massive development pipeline, signaling an aggressive growth strategy.

A landmark court decision certifies a massive class action against Johnson & Johnson, alleging its Baby Powder caused cancer and the company misled consumers.

As Sweden nears smoke-free status with nicotine pouches, Argentina's ban on alternatives leaves millions of women at risk. A new report ignites the debate.

Celebrating its 2nd anniversary, Hong Kong's anti-corruption academy is exporting its expertise with AI-powered training and a new regional focus.

Praxis Solutions' new WealthHawk platform uses AI to find clients at key life events, aiming to end cold calling and solve the organic growth puzzle.

A new partnership aims to solve the flexible film waste crisis, spurred by tough new laws that are forcing the packaging industry to innovate or pay.

A new partnership sees Veritone's AI unlock The Washington Post's video vault, aiming to monetize history while protecting journalistic integrity.

OmniAb reported declining revenue and a wider net loss for 2025, even as it launched its revolutionary OmniUltra platform and its partners' drugs advance.

The energy services firm surpassed analyst expectations with strong revenue growth and a key acquisition, but warns of a challenging year ahead.

Svitla Systems lands on the 2026 IAOP Global Outsourcing 100 list, recognized for its AI innovation, 90% client retention, and responsible growth.

New module built on Microsoft Purview aims to help firms navigate AI ethics, data risks, and mounting compliance pressures with legal-specific controls.

As AI reshapes how patients get health info, new services aim to protect brands from inaccuracy, compliance risks, and reputational damage.

Amid a booming gene therapy market, Oxford Biomedica Solutions launches key investor events to showcase its strategy and secure its leadership position.

The digital asset giant is delisting from Toronto to streamline costs, a move that reshapes its buyback plan and how Canadian investors trade its stock.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.

The new M² card aims to redefine crypto spending with self-custody, user-approved transactions, and a deep integration with decentralized digital identity.